For this study, researchers accessed data from MedAssurant’s Medical Outcomes Research for Effectiveness and Economics Registry, which contains more than 5.2 billion healthcare events from 77 million unique de-identified individuals.
The researchers discovered the unadjusted 30-day readmission rate for Medicare Advantage patients was 14.5 percent from 2006-2008, compared to a 36.5 percent 30-day readmission rate for Medicare fee-for-service patients in the same time period. This trend held true after adjusting for risk and demographic factors. Specifically, the adjusted 30-day readmission rate for Medicare Advantage patients was 13-20 percent lower than Medicare fee-for-service rates.
Related Articles on Readmissions:
Q&A With Johns Hopkins’ Dr. Peter Pronovost: How Clinical Communities Can Reduce Harm
Faster, Better, Stronger: Reinforcing Ties Between Hospitalists and Emergency Medicine
AT&T, Intuitive Health Partner for Readmission Pilot
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
